Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition

Yu Chen Lee, Song Chang Lin, Guoyu Yu, Ming Zhu, Jian H. Song, Keith Rivera, Darryl J. Pappin, Christopher J. Logothetis, Theocharis Panaretakis, Guocan Wang, Li Yuan Yu-Lee, Sue Hwa Lin

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Metastatic prostate cancer (PCa) in bone induces bone-forming lesions that enhance PCa progression. How tumor-induced bone formation enhances PCa progression is not known. We have previously shown that PCa-induced bone originates from endothelial cells (ECs) that have undergone endothelial-to-osteoblast (EC-to-OSB) transition by tumor-secreted bone morphogenetic protein 4 (BMP4). Here, we show that EC-to-OSB transition leads to changes in the tumor microenvironment that increases the metastatic potential of PCa cells. We found that conditioned medium (CM) from EC-OSB hybrid cells increases the migration, invasion, and survival of PC3-mm2 and C4-2B4 PCa cells. Quantitative mass spectrometry (Isobaric Tags for Relative and Absolute Quantitation) identified Tenascin C (TNC) as one of the major proteins secreted from EC-OSB hybrid cells. TNC expression in tumor-induced OSBs was confirmed by immunohistochemistry of MDA PCa-118b xenograft and human bone metastasis specimens. Mechanistically, BMP4 increases TNC expression in EC-OSB cells through the Smad1-Notch/Hey1 pathway. How TNC promotes PCa metastasis was next interrogated by in vitro and in vivo studies. In vitro studies showed that a TNC-neutralizing antibody inhibits EC-OSB-CM-mediated PCa cell migration and survival. TNC knockdown decreased, while the addition of recombinant TNC or TNC overexpression increased migration and anchorage-independent growth of PC3 or C4-2b cells. When injected orthotopically, PC3-mm2-shTNC clones decreased metastasis to bone, while C4-2b-TNC-overexpressing cells increased metastasis to lymph nodes. TNC enhances PCa cell migration through α5β1 integrin-mediated YAP/TAZ inhibition. These studies elucidate that tumor-induced stromal reprogramming generates TNC that enhances PCa metastasis and suggest that TNC may be a target for PCa therapy.

Original languageEnglish (US)
Pages (from-to)757-769
Number of pages13
JournalOncogene
Volume41
Issue number6
DOIs
StatePublished - Feb 4 2022

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

MD Anderson CCSG core facilities

  • Research Animal Support Facility
  • Cytogenetics and Cell Authentication Core
  • Tissue Biospecimen and Pathology Resource
  • Advanced Technology Genomics Core
  • Small Animal Imaging Facility

Fingerprint

Dive into the research topics of 'Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition'. Together they form a unique fingerprint.

Cite this